Maharashtra FDA widens crackdown on drug quality, misleading ads and online sales
Maharashtra’s FDA plans stronger action against fake and substandard medicines, misleading health advertising, illegal online drug sales and non-compliant healthcare products. The regulator has received 1,600 complaints through its online grievance portal and is also pursuing food-safety violations.
Maharashtra FDA will widen enforcement against fake and substandard medicines, misleading health advertisements, illegal online drug sales and non-compliant healthcare products, alongside food-safety raids. The regulator is recalling NSQ drugs and says violations by pharmacies, hospitals and food businesses will face action.
Why this matters
The drug and online-sales push extends Maharashtra FDA’s recent enforcement pattern: it suspended about 60 food-business licences after 600 inspections, gave eateries two weeks to fix hygiene breaches, and inspected Bombay High Court canteens.
Retail-company signals are accelerating, up 218683% QoQ.